Comparison of pathogens and their antimicrobial resistance patterns in paediatric, adult and elderly patients in Canadian hospitals

Changing epidemiology of methicillin-resistant Staphylococcus aureus in Canada

(2013) K. A. Nichol et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study

(2013) G. G. Zhanel et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Molecular epidemiology of extended-spectrum  -lactamase-, AmpC  -lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11

(2013) A. J. Denisuik et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Increased multi-drug resistance among the elderly on admission to the hospital—A 12-year surveillance study

(2012) Claudia M. Denkinger et al.   ARCHIVES OF GERONTOLOGY AND GERIATRICS

Sex, drugs, bugs, and age: Rational selection of empirical therapy for outpatient urinary tract infection in an era of extensive antimicrobial resistance

(2012) Jaime L. Rocha et al.   Brazilian Journal of Infectious Diseases

Antimicrobial resistance trends among 5608 clinical Gram-positive isolates in China: results from the Gram-Positive Cocci Resistance Surveillance program (2005–2010)

(2012) Chunjiang Zhao et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Antimicrobial Resistance in More than 100,000Escherichia coliIsolates According to Culture Site and Patient Age, Gender, and Location

(2011) José Miguel Sahuquillo-Arce et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Susceptibility to Tigecycline and Linezolid Among Gram-Positive Isolates Collected in the United States as Part of the Tigecycline Evaluation and Surveillance Trial (TEST) Between 2004 and 2009

(2011) Michael J. Dowzicky   CLINICAL THERAPEUTICS

Epidemiology of Streptococcus pneumoniae in France before introduction of the PCV-13 vaccine

(2011) N. Grall et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Baseline Epidemiology of Streptococcus pneumoniae Serotypes in Canada Prior to the Introduction of the 13-Valent Pneumococcal Vaccine

(2011) Heather J. Adam et al.   Microbial Drug Resistance

Antimicrobial Susceptibilities of Health Care-Associated and Community-Associated Strains of Methicillin-Resistant Staphylococcus aureus from Hospitalized Patients in Canada, 1995 to 2008

(2010) A. E. Simor et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000–2006

(2009) Gregory J. Tyrrell et al.   VACCINE

The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000–2007

(2009) Julie A. Bettinger et al.   VACCINE

Antimicrobial-Resistant Pathogens in Intensive Care Units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) Study, 2005-2006

(2008) G. G. Zhanel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: Results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007

(2008) Michael J. Dowzicky et al.   CLINICAL THERAPEUTICS

Antimicrobial activity of ceftobiprole, a novel anti–methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005–2006)

(2008) Thomas R. Fritsche et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE